Skip to main content
    V

    Veracyte Inc (VCYT)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $24.23
    +0.22 (+0.92%)

    Market Cap: $1.94B

    Last updated: Nov 17, 2026 at 5:47 PM ET

    Veracyte Inc (VCYT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Veracyte (VCYT) has a market cap of $1.94B and an enterprise value of $1.74B. Its trailing P/E is 13.5x.

    Total Valuation

    Enterprise value is 9.97% below the market cap, as cash exceeds debt.

    Market Cap$1.94B
    Enterprise Value$1.74B
    Latest price (Nov 17, 2026)$24.23

    Key Dates

    The next earnings report is expected on Feb 22, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 22, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.66% in the quarter ended Sep 30, 2026 and grew 2.24% a year over 2 years.

    Shares Outstanding80.50M
    Shares Change (YoY)+2.26%
    Shares Change (QoQ)+0.66%
    Share Count Growth (2Y CAGR)+2.24%

    Valuation Ratios

    Sales and book value multiples are 3.4x and 1.4x.

    P/E Ratio13.5x
    Forward P/E12.4x
    P/S Ratio3.4x
    Forward P/S3.3x
    P/B Ratio1.4x
    P/TBV Ratio5.0x
    P/FCF Ratio12.0x
    P/OCF Ratio11.1x
    PEG Ratio0.4

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 12.8x EBITDA and 10.9x free cash flow.

    EV / Earnings13.8x
    EV / Sales3.0x
    EV / EBITDA12.8x
    EV / EBIT14.8x
    EV / FCF10.9x

    Price Statistics

    The stock is down 38.42% over 52 weeks and trades 41.52% below its 50-day average.

    Beta (1Y)3.19
    52-Week Change-38.42%
    1-Month Change-44.68%
    3-Month Change-42.57%
    6-Month Change-41.88%
    5-Year Change+4.45%
    10-Year Change+588.84%
    Total Return (1Y)-38.42%
    Total Return (3Y CAGR)-1.36%
    Total Return (5Y CAGR)-11.84%
    Return vs SPY (1Y)-49.05%
    Max Drawdown (1Y)-60.32%
    Max Drawdown (3Y)-60.32%
    Sharpe Ratio (1Y)-0.48
    Correlation with SPY (1Y)0.45
    50-Day Average$41.43
    200-Day Average$42.24
    52-Week Range$21.91 to $60.91
    RSI (14 Days)28.3
    Average Volume (20 Days)2.87M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.56x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio5.56x
    Quick Ratio5.25x
    Debt / Equity0.00x
    Debt / EBITDA0.05x
    Debt / FCF0.04x

    Returns and Efficiency

    Return on invested capital is 8.21% over the last 12 months, against a 5-year average of 5.06%.

    Return on Equity (ROE)8.85%
    Return on Assets (ROA)8.06%
    Return on Invested Capital (ROIC)8.21%
    Return on Capital Employed (ROCE)7.94%
    ROE (5Y Average)-2.06%
    ROA (5Y Average)-1.92%
    ROIC (5Y Average)5.06%
    Asset Turnover0.40x
    Inventory Turnover6.59x
    Receivables Turnover10.49x
    Cash Conversion Cycle70 days

    Scores

    VCYT has an Altman Z-Score of 9.01, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score9.01
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $581.78M over the last 12 months is up 17.50% from the 12 months before.

    Revenue$581.78M
    Revenue Growth (YoY)+17.50%
    Gross Profit$418.79M
    Operating Income$99.39M
    Pretax Income$118.25M
    Net Income$126.85M
    EBITDA$136.77M
    EBIT$118.25M
    Reported EPS (TTM)$1.80

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 91.08% of the $1.57B in total assets.

    Cash and Equivalents$199.83M
    Total Debt$6.73M
    Net Cash$193.09M
    Net Cash Per Share$2.40
    Working Capital$383.67M
    Shareholder Equity$1.43B
    Book Value Per Share$17.80
    Tangible Book Value$392.81M
    Tangible Book Per Share$4.88
    Total Assets$1.57B
    Total Liabilities$139.99M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $11.94M of capital spending, operating cash flow left $161.95M of free cash flow.

    Operating Cash Flow$173.88M
    Capital Expenditures$11.94M
    Free Cash Flow$161.95M
    FCF Per Share$2.01
    Depreciation and Amortization$24.58M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 17.08%, against a 5-year average of -12.03%.

    Gross Margin71.98%
    Operating Margin17.08%
    Pretax Margin20.33%
    Net Margin21.80%
    EBITDA Margin23.51%
    EBIT Margin20.33%
    FCF Margin27.84%
    Gross Margin (5Y Average)65.19%
    Operating Margin (5Y Average)-12.03%
    Net Margin (5Y Average)-9.82%

    Growth

    Revenue grew 20.37% a year over 3 years.

    Revenue Growth (3Y CAGR)+20.37%
    Revenue Growth (5Y CAGR)+34.50%
    Book Value Per Share Growth (2Y CAGR)+6.14%
    Tangible Book Per Share Growth (2Y CAGR)+26.98%

    Revenue and profit by year

    Dividends and Yields

    VCYT does not pay a dividend. Its free cash flow yield is 8.30%.

    Earnings Yield7.41%
    FCF Yield8.30%
    Shareholder Yield0.00%

    Peer Position

    Against 4 similar companies, VCYT has the lowest P/E.

    P/E Ratio13.5x vs 37.7x median
    P/S Ratio3.4x vs 3.2x median
    ROIC8.21% vs -5.77% median
    Revenue Growth (Trailing 4 Quarters, YoY)+17.50% vs +10.43% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 10.75% and EPS growth at -6.45% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+10.75%
    EPS Growth Forecast (2Y CAGR)-6.45%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About VCYT

    What is VCYT's market cap?

    Veracyte has a market cap of $1.94B. Its enterprise value, which adds debt and subtracts cash, is $1.74B.

    What is VCYT's P/E ratio?

    Veracyte has a trailing P/E ratio of 13.5x and a forward P/E of 12.4x.

    How many shares of VCYT are outstanding?

    Veracyte has 80.50M shares outstanding. The count is up 2.26% from a year earlier.

    Does VCYT pay a dividend?

    No. Veracyte does not pay a dividend.

    How much debt does VCYT have?

    Veracyte has $6.73M of total debt and $199.83M of cash and equivalents, a net cash position of $193.09M.